Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Young

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Toxicology and Environmental Health. Part A|November 13, 2003
The prediction of methylmercury elimination half-life in humans using animal data: a neural network/rough sets analysisRay R Hashemi, John F Young
Journal of Chemical Information and Computer Sciences|May 25, 2004
Discriminant function analyses of liver-specific carcinogensRichard D Beger, John F Young, Hong Fang
Chemical Research in Toxicology|February 28, 2007
Physiologically based pharmacokinetic/pharmacodynamic model for acrylamide and its metabolites in mice, rats, and humansJohn F Young, Richard H Luecke, Daniel R Doerge
Dalton Transactions (Cambridge, England : 2003)|March 16, 2013
A well-defined model system for the chromium-catalyzed selective oligomerization of ethyleneWesley H Monillas, John F Young, Glenn P A Yap, et al.
Acta Crystallographica. Section C, Structural Chemistry|May 5, 2022
A molecular substitutional disorder case study suitable for instruction: L<sub>2</sub>Cr<sup>II</sup>(THF)/L<sub>2</sub>[(trimethylsilyl)methyl]Cr<sup>III</sup> (L is 2,5-bis{[(2,6-diisopropylphenyl)imino]methyl}pyrrol-1-ide)Brian A Salisbury, John F Young, Klaus H Theopold, et al.
Journal of Toxicology and Environmental Health. Part A|May 15, 2007
Postnatal growth considerations for PBPK modelingRichard H Luecke, Bruce A Pearce, Walter D Wosilait, et al.
Basic & Clinical Pharmacology & Toxicology|May 17, 2006
Steady state pharmacokinetics of oral treatment with 13-cis-retinoic acid or all-trans-retinoic acid in male and female adult ratsSherry A Ferguson, Paul H Siitonen, F Javier Cisneros, et al.
Toxicology and Applied Pharmacology|January 26, 2005
Toxicokinetics of acrylamide and glycidamide in B6C3F1 miceDaniel R Doerge, John F Young, L Patrice McDaniel, et al.
Journal of Toxicology and Environmental Health. Part A|July 21, 2006
Database composition can affect the structure-activity relationship predictionJohn F Young, Chen-An Tsai, James J Chen, et al.
Journal of Agricultural and Food Chemistry|July 16, 2008
Using dietary exposure and physiologically based pharmacokinetic/pharmacodynamic modeling in human risk extrapolations for acrylamide toxicityDaniel R Doerge, John F Young, James J Chen, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Toxicology and Environmental Health. Part A|November 13, 2003
The prediction of methylmercury elimination half-life in humans using animal data: a neural network/rough sets analysisRay R Hashemi, John F Young
Journal of Chemical Information and Computer Sciences|May 25, 2004
Discriminant function analyses of liver-specific carcinogensRichard D Beger, John F Young, Hong Fang
Chemical Research in Toxicology|February 28, 2007
Physiologically based pharmacokinetic/pharmacodynamic model for acrylamide and its metabolites in mice, rats, and humansJohn F Young, Richard H Luecke, Daniel R Doerge
Dalton Transactions (Cambridge, England : 2003)|March 16, 2013
A well-defined model system for the chromium-catalyzed selective oligomerization of ethyleneWesley H Monillas, John F Young, Glenn P A Yap, et al.
Acta Crystallographica. Section C, Structural Chemistry|May 5, 2022
A molecular substitutional disorder case study suitable for instruction: L<sub>2</sub>Cr<sup>II</sup>(THF)/L<sub>2</sub>[(trimethylsilyl)methyl]Cr<sup>III</sup> (L is 2,5-bis{[(2,6-diisopropylphenyl)imino]methyl}pyrrol-1-ide)Brian A Salisbury, John F Young, Klaus H Theopold, et al.
Journal of Toxicology and Environmental Health. Part A|May 15, 2007
Postnatal growth considerations for PBPK modelingRichard H Luecke, Bruce A Pearce, Walter D Wosilait, et al.
Basic & Clinical Pharmacology & Toxicology|May 17, 2006
Steady state pharmacokinetics of oral treatment with 13-cis-retinoic acid or all-trans-retinoic acid in male and female adult ratsSherry A Ferguson, Paul H Siitonen, F Javier Cisneros, et al.
Toxicology and Applied Pharmacology|January 26, 2005
Toxicokinetics of acrylamide and glycidamide in B6C3F1 miceDaniel R Doerge, John F Young, L Patrice McDaniel, et al.
Journal of Toxicology and Environmental Health. Part A|July 21, 2006
Database composition can affect the structure-activity relationship predictionJohn F Young, Chen-An Tsai, James J Chen, et al.
Journal of Agricultural and Food Chemistry|July 16, 2008
Using dietary exposure and physiologically based pharmacokinetic/pharmacodynamic modeling in human risk extrapolations for acrylamide toxicityDaniel R Doerge, John F Young, James J Chen, et al.
Pageof 2